Md. biotech working on organ evaluation service

Silver Spring-based United Therapeutics Corp., a subsidiary of XVIVO Perfusion AB, announced Tuesday XVIVO's ex-vivo lung perfusion technology will be incorporated into the laboratory of Lung Bioengineering Inc., a subsidiary of United Therapeutics' public benefit corporation subsidiary Lung Biotechnology PBC. Lung Bioengineering has agreed to purchase multiple XVIVO Perfusion System machines from XVIVO Perfusion for use in ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *